Dopaminergic Cell Loss Induced by Human A30P α-Synuclein Gene Transfer to the Rat Substantia Nigra-Reference-Cited by-同舟云学术

Dopaminergic Cell Loss Induced by Human A30P α-Synuclein Gene Transfer to the Rat Substantia Nigra

Published:2002-03-20 Issue:5 Volume:13 Page:605-612
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Klein Ronald L.¹,King Michael A.²,Hamby Mary E.¹,Meyer Edwin M.¹

Affiliation:

1. Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, FL 32610-0267

2. Veterans Administration Gainesville Medical Center and Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL 32610-0244

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/10430340252837206

Reference33 articles.

1. Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in Brain

2. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha -synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy

3. Neonatal Intramuscular Injection with Recombinant Adeno-Associated Virus Results in Prolonged beta-Glucuronidase Expression in Situ and Correction of Liver Pathology in Mucopolysaccharidosis Type VII Mice

4. Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system

5. Tau and Synuclein and Their Role in Neuropathology

Cited by 186 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-transgenic models of Parkinson's disease: The pursuit of a resemblance;Brain Disorders;2024-06

2. Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegeneration;2024-05-05

3. Recalibrating the Why and Whom of Animal Models in Parkinson Disease: A Clinician’s Perspective;Brain Sciences;2024-01-31

4. Pre-clinical Aspects and Contemporary Treatments of Parkinson’s Disease;CNS & Neurological Disorders - Drug Targets;2023-10-06

5. Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats;Current Research in Neurobiology;2023